光子计数探测器CT在体外灌注人体尸体模型中对股动脉支架成像的研究
在1具人体尸体中建立连续体外灌注模型,于双侧股动脉植入7枚外周支架,比较第一代双源光子计数探测器CT(PCD-CT)与第三代双源能量积分探测器CT(EID-CT)在股动脉流出道支架成像中的表现。PCD-CT最大支架内管腔可见度为94.48%±2.62%,最低可见度方案(BV40:78.93%±4.67%)与EID-CT最佳方案(BV59:79.49%±2.64%,P>0.999)相当;PCD-CT的CNR在任何卷积核和剂量水平均优于EID-CT(P<0.001),理论剂量降低潜力分别为BV40 88%、BV48/49 83%、BV59/60 73%。
要点
- PCD-CT最大支架内管腔可见度为94.48%±2.62%,最低可见度方案与EID-CT最佳方案相当(P>0.999)。
- PCD-CT的CNR在任何卷积核和剂量水平均优于EID-CT(P<0.001),最高CNR为48.8±17.4 vs 31.28±5.7(均为BV40高剂量)。
- PCD-CT相对EID-CT的理论剂量降低潜力为BV40 88%、BV48/49 83%、BV59/60 73%。
核心结论
- 在连续灌注的人体尸体模型中,PCD-CT凭借更优的管腔可见度和CNR,可在维持图像质量的同时较EID-CT明显降低剂量。
研究设计与样本
- 在1具人体尸体中通过腹股沟及膝下入路和蠕动泵建立连续体外灌注,经皮血管成形术于双侧股浅动脉植入7枚外周支架,行辐射剂量等效CT血管成像(高/中/低剂量:10/5/3 mGy),管电压固定120 kVp,匹配迭代重建算法级别和卷积核,分别使用PCD-CT与EID-CT。
关键影像表现/征象
- PCD-CT最大支架内管腔可见度为94.48%±2.62%。
- PCD-CT管腔可见度最低的方案(BV40:78.93%±4.67%)与EID-CT管腔可见度最佳的方案(BV59:79.49%±2.64%,P>0.999)表现相当。
- PCD-CT在任何卷积核和剂量水平下CNR均优于EID-CT(P<0.001)。
- 最高CNR在PCD-CT为48.8±17.4,在EID-CT为31.28±5.7(均为BV40高剂量)。
- 任何方案中支架内衰减与支架外管腔衰减均无显著差异。
诊断标准与关键数值
- PCD-CT相对EID-CT的理论剂量降低潜力为BV40 88%、BV48/49 83%、BV59/60 73%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND AIMS: This study aims to compare the performance of first-generation dual-source photon-counting detector computed tomography (PCD-CT) to third-generation dual-source energy-integrating detector (EID-CT) regarding stent imaging in the femoral arterial runoff.
METHODS: Continuous extracorporeal perfusion was established in 1 human cadaver using an inguinal and infragenicular access and peristaltic pump. Seven peripheral stents were implanted into both superior femoral arteries by means of percutaneous angioplasty. Radiation dose-equivalent CT angiographies (high-/medium-/low-dose: 10/5/3 mGy) with constant tube voltage of 120 kVp, matching iterative reconstruction algorithm levels, and convolution kernels were used both with PCD-CT and EID-CT. In-stent lumen visibility, luminal and in-stent attenuation as well as contrast-to-noise ratio (CNR) were assessed via region of interest and diameter measurements. Results were compared using analyses of variance and regression analyses.
RESULTS: Maximum in-stent lumen visibility achieved with PCD-CT was 94.48% ± 2.62%. The PCD-CT protocol with the lowest lumen visibility (BV40: 78.93% ± 4.67%) performed equal to the EID-CT protocol with the best lumen visibility (BV59: 79.49% ± 2.64%, P > 0.999). Photon-counting detector CT yielded superior CNR compared with EID-CT regardless of kernel and dose level ( P < 0.001). Maximum CNR was 48.8 ± 17.4 in PCD-CT versus 31.28 ± 5.7 in EID-CT (both BV40, high-dose). The theoretical dose reduction potential of PCD-CT over EID-CT was established at 88% (BV40), 83% (BV48/49), and 73% (BV59/60), respectively. In-stent attenuation was not significantly different from luminal attenuation outside stents in any protocol.
CONCLUSIONS: With superior lumen visibility and CNR, PCD-CT allowed for noticeable dose reduction over EID-CT while maintaining image quality in a continuously perfused human cadaveric model.
引用
- Hartung V, Gruschwitz P, Huflage H, et al. Photon-Counting Detector CT for Femoral Stent Imaging in an Extracorporeally Perfused Human Cadaveric Model. Invest Radiol. 2023. PMID: 37812470. doi:10.1097/RLI.0000000000001019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。